10-Q: U.S. Physical Therapy Reports Strong Q3 Growth, Expands Clinic Network

U.S. Physical Therapy, Inc. announced significant revenue and profit increases for the third quarter and first nine months of 2025, driven by strategic acquisitions and higher patient volumes.

Summary

• Net revenue for the third quarter of 2025 increased by 17.3% to $197.1 million, up from $168.0 million in the prior year quarter.
• Net income attributable to USPH shareholders for the third quarter of 2025 surged by 98.2% to $13.1 million, compared to $6.6 million in the third quarter of 2024.
• Basic and diluted earnings per share attributable to USPH shareholders rose to $0.48 for the third quarter of 2025, from $0.39 in the same period last year.
• For the nine months ended September 30, 2025, net revenue grew by 17.8% to $578.3 million, up from $490.9 million in the comparable prior year period.
• Net income attributable to USPH shareholders for the nine months increased by 59.7% to $35.4 million, compared to $22.2 million in the first nine months of 2024.
• Basic and diluted earnings per share for the nine months reached $1.85, up from $1.32 in the prior year period.
• The company added 18 clinics and closed 7 in the third quarter of 2025, bringing the total owned and/or managed clinics to 779 as of September 30, 2025, compared to 700 a year prior.
• Total patient visits for the third quarter increased by 18.0% to 1,554,207, including 30,137 home-care visits.
• Average daily patient visits per clinic (excluding home-care) reached a record-high 32.2 for the third quarter of 2025.
• The Industrial Injury Prevention Services (IIP) segment saw revenue increase by 14.6% to $29.0 million for the third quarter and 21.6% to $85.5 million for the nine months.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance with significant increases in revenue, net income, and EPS for both the quarter and nine-month periods. Strategic acquisitions and organic growth in patient visits contributed to these positive results. The approval of a share repurchase program further enhances shareholder value. While there was a slight dip in quarterly non-GAAP operating results per share and lower interest income due to cash deployment, the overall trajectory and strategic execution are highly positive.

Positives

• Strong revenue growth in both physical therapy operations (+17.8% for Q3, +17.2% for 9M) and Industrial Injury Prevention Services (+14.6% for Q3, +21.6% for 9M).
• Significant increase in GAAP net income attributable to USPH shareholders (+98.2% for Q3, +59.7% for 9M).
• Basic and diluted EPS showed substantial improvement (+23.1% for Q3, +39.4% for 9M).
• Adjusted EBITDA (non-GAAP) increased by 13.2% for Q3 and 17.2% for 9M, indicating healthy operational performance.
• Clinic network expansion with 84 net owned clinics added since the comparable prior year period, contributing to increased patient visits.
• Average daily patient visits per clinic reached a record-high volume of 32.2 for a third quarter.
• A net gain of $5.9 million was recognized from the revaluation of contingent earn-out consideration in Q3 2025, compared to a net loss in Q3 2024.
• The Board of Directors approved a share repurchase program of up to $25.0 million, signaling confidence in the company's valuation and commitment to shareholder returns.
• The 'One Big Beautiful Bill Act' signed on July 4, 2025, reinstates 100% bonus depreciation and provides more favorable deductibility for certain business expenses, which could benefit future tax positions.

Negatives

• Non-GAAP Operating Results per share slightly decreased to $0.66 for the third quarter of 2025 from $0.69 in the prior year quarter.
• Interest income from investments significantly decreased to less than $0.1 million in Q3 2025 from $1.0 million in Q3 2024, due to cash deployment for acquisitions.
• Cash provided by operating activities decreased to $50.1 million for the nine months ended September 30, 2025, from $55.5 million in the prior year period, primarily due to increased accounts receivable and a decrease in accounts payable and accrued expenses.
• Corporate office costs increased by 21.1% for Q3 and 19.7% for 9M, attributed to supporting a larger clinic network, acquisition integration, and new financial/HR system implementation.
• A net non-cash expense of $0.7 million was recognized from the revaluation of a put-right liability in Q3 2025, compared to a net non-cash gain in Q3 2024.
• Medicare reimbursement for therapy services decreased by approximately 2.9% for 2025, posing a challenge to revenue rates.

Risks

• Changes in Medicare rules, guidelines, and reimbursement rates, or failure to maintain Medicare certification/enrollment status.
• Potential retroactive reduction of revenue from Medicare and Medicaid programs.
• Adoption of payment policies by private third-party payors that could limit future revenue and profitability.
• Compliance with federal and state laws and regulations related to patient information privacy (HIPAA) and corporate practice of medicine/fee splitting, with associated fines and penalties.
• Competitive, economic, or reimbursement conditions in markets that may necessitate clinic reorganization or closure, leading to losses or asset write-downs.
• Impact of future public health crises and epidemics/pandemics on operations.
• Acquisition agreements containing put-rights related to future purchases of significant equity interests in subsidiaries or separate companies.
• Impact of future vaccination and/or testing mandates on staffing, revenue, and costs.
• Debt and financial obligations could adversely affect financial condition, ability to obtain future financing, and business operations.
• Changes resulting from government-enacted national healthcare reform.
• Ability to control variable interest entities for which the company does not have direct ownership.
• Governmental and other third-party payor inspections, reviews, investigations, and audits, potentially resulting in sanctions, reputational harm, and increased costs.
• Contingent consideration provisions in acquisition agreements, the value of which may impact future financial results.
• Legal actions that could lead to increased operating costs and uninsured liabilities.
• General economic conditions, including inflationary and recessionary periods, and banking volatility or adverse developments in financial systems.
• Dependence on hiring, training, and retaining qualified employees, particularly physical therapists.
• Competitive environment in the industrial injury prevention services business, potentially leading to contract termination or non-renewal.
• Ability to identify and complete acquisitions, and successfully integrate acquired businesses.
• Impact on business and cash reserves from retirement or resignation of key partners and resulting purchase of their non-controlling interest.
• Maintaining information technology systems with adequate safeguards against cyber-attacks and potential security breaches.
• Maintaining clients for management, industrial injury prevention, and other services, as contract breaches or terminations could adversely affect operating results.
• Maintaining adequate internal controls.
• Maintaining necessary insurance coverage.
• Availability, terms, and use of capital.
• Weather and other seasonal factors affecting operations.

Future Outlook

The company's strategy is to continue acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices, develop satellite clinics in existing partnerships, and acquire industrial injury prevention services companies. Management believes current cash and credit facilities are sufficient to fund working capital and growth opportunities through at least September 30, 2026. The proposed 2026 Medicare Physician Fee Schedule is expected to increase Medicare reimbursement for therapy services by approximately 1.5% compared to 2025 rates.

Management Comments

• Our strategy is to continue acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices, to develop outpatient physical therapy clinics as satellites in existing partnerships, and to continue acquiring companies that provide industrial injury prevention services.
• Our Board of Directors declared a quarterly dividend of $0.45 per share payable on December 12, 2025, to shareholders of record on November 17, 2025.
• Our Company's Board of Directors approved a share repurchase program effective August 5, 2025. The program authorizes the repurchase by the Company of up to $25.0 million of its outstanding shares of common stock over the period ending on December 31, 2026.
• We believe that our business has sufficient cash to allow us to meet our short-term cash requirements.
• We believe that our cash and cash equivalents and availability under our Senior Credit Facilities are sufficient to fund the working capital needs of our operating subsidiaries through at least September 30, 2026.

Industry Context

U.S. Physical Therapy, Inc. operates in the dynamic U.S. healthcare services sector, specifically in physical, occupational, and speech therapy, and industrial injury prevention. The industry faces ongoing challenges from changes in Medicare reimbursement rates, which saw a 2.9% decrease for therapy services in 2025, though a 1.5% increase is proposed for 2026. The company's aggressive acquisition strategy and expansion into home-care and industrial injury prevention services reflect a broader trend of consolidation and diversification within the fragmented therapy market, aiming to capture growth opportunities and mitigate regulatory pressures. The 'One Big Beautiful Bill Act' is a relevant legislative development impacting business tax deductions.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• The company is a party to various legal actions, proceedings, claims, and regulatory/governmental audits in the ordinary course of business.
• Cannot predict the ultimate outcome of pending litigation, which could result in sanctions, damages, recoupments, fines, and other penalties.
• Subject to potential additional investigations by the Department of Justice, CMS, or other federal and state enforcement agencies.
• Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act, which can involve significant monetary damages and penalties.

Related Party Transactions

• The Company leases certain properties from Michael G. Mayrsohn, President of Metro and a Board of Directors member. Total lease payments of $0.4 million were made to Mr. Mayrsohn for the nine months ended September 30, 2025.
• Metro has made leasehold improvements valued at $0.3 million as of September 30, 2025, on properties leased from Mr. Mayrsohn.
• The total minimum future rental payments under these related party lease agreements is $2.8 million as of September 30, 2025.

Stakeholder Impact

• Shareholders: Benefited from increased net income and EPS, and the declaration of a quarterly dividend. The share repurchase program indicates potential for further shareholder value enhancement.
• Employees: Continued growth through acquisitions and clinic additions may create more employment opportunities. Compensation expense for equity-based awards increased.
• Customers (Patients): Expansion of clinic network and home-care services provides broader access to physical, occupational, and speech therapy.
• Suppliers/Creditors: Increased operating costs and debt levels (revolving facility) suggest higher activity, but the company remains in compliance with debt covenants.
• Partners (Non-controlling interests): Net income attributable to non-controlling interests increased, and the value of redeemable non-controlling interests also grew, reflecting their share in the company's performance.

Next Steps

• Continue acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices.
• Develop outpatient physical therapy clinics as satellites in existing partnerships.
• Continue acquiring companies that provide industrial injury prevention services.
• Implement the share repurchase program of up to $25.0 million through December 31, 2026.
• Monitor and evaluate interpretive guidance and incremental impacts of the 'One Big Beautiful Bill Act' in subsequent periods.
• Include required enhanced disclosures from ASU 2023-09 in the Annual Report on Form 10-K for the year ending December 31, 2025.
• Continue implementation of the new financial and human resources system through the end of 2026.

Key Dates

Recommendation

U.S. Physical Therapy, Inc. delivered robust financial results, with substantial year-over-year growth in revenue, net income, and EPS for both the quarter and nine-month periods. The company's aggressive expansion strategy through acquisitions, coupled with organic growth in patient visits, demonstrates effective execution in a growing healthcare segment. The approval of a $25.0 million share repurchase program signals management's confidence and commitment to shareholder returns. While Medicare reimbursement rates present a persistent challenge, the company's diversification into industrial injury prevention and home-care services, along with its strong operational performance, positions it well for continued growth. The slight dip in quarterly non-GAAP operating results per share is minor in the context of overall strong GAAP performance and strategic initiatives.

Keywords

Physical Therapy, Healthcare Services, SEC Filing, 10-Q, USPH, Industrial Injury Prevention, Clinic Expansion, Acquisitions, Earnings Report, Medicare Reimbursement, Financial Performance, Outpatient Therapy, Corporate Wellness